Product logins

Find logins to all Clarivate products below.


Therapeutic Botulinum Toxin | Global | 2014 | Market Analysis

The global therapeutic BTX market will be grow robustly through 2022, with significant procedure and unit sales growth being driven by newly approved indications, the need for repeat BTX treatments, and a largely favorable reimbursement environment.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for therapeutic BTX in the US, France, Germany, Italy, Spain, the UK and Japan across a 10-year period.

Related Medtech Insights Reports

Report
Therapeutic Botulinum Toxin – Market Insights – Global
Global therapeutic BTX procedure volumes—and thus product sales and revenues—will be supported by the need for existing patients to return for maintenance procedures, as well as rising demand…
Report
Therapeutic Botulinum Toxin | Market Insights | Global | 2024
Global therapeutic BTX procedure volumes—and thus product sales and revenues—will be supported by the need for existing patients to return for maintenance procedures, as well as rising…
Report
Therapeutic Botulinum Toxin | Market Insights | Global | 2023
Despite the negative impact of the COVID-19 pandemic, the global market for therapeutic BTX will exhibit rapid growth through 2031. The need to return for maintenance procedures will sustain…
Report
Therapeutic Botulinum Toxin | Market Insights | Global | 2022
In 2020, the global therapeutic BTX market was negatively impacted by the COVID-19 pandemic. Although some procedures have begun to recover, some procedures are still being deferred. That said…
Report
Therapeutic Botulinum Toxin | Market Insights | Global | 2021
The COVID-19 pandemic will have a negative short-term effect on the global therapeutic BTX market. The deferral of nonurgent procedures, compounded with economic uncertainty across the globe…